Cite
HARVARD Citation
Ferry, D. et al. (2017). Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial. European journal of cancer. pp. 302-312. [Online].